However, improvement in patient global impression of change (PGIC) and clinical global impression for deutetrabenazine and PGIC for valbenazine did not reach statistical significance.
← all excerpts
Tardive dyskinesia in Asia- current clinical practice and the role of neurologists in the care pathway.
1
—
—